Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews
BackgroundNew ways of reimbursement for high-cost, one-shot curative therapies such as advanced therapy medicinal products (ATMPs) are a growing area of interest to stakeholders in market access such as industry representatives, legislative and accounting experts, physicians, hospital managers, hosp...
Saved in:
Main Authors: | Thomas Desmet, Sissel Michelsen, Elena Van den Brande, Walter Van Dyck, Steven Simoens, Isabelle Huys |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1397531/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Common spine codes are reimbursed 13% less by Medicaid compared to Medicare, ranging from 46% to 160% by state
by: Adam P. Henderson, BS, et al.
Published: (2025-03-01) -
Experience of Student Entrepreneurs in the Implementation of Businesses Financed with Non-Reimbursable Funds
by: Dragomir Camelia-Cristina, et al.
Published: (2024-12-01) -
The value-for-money assessment and funding arrangements for high-priced drugs in an era of uncertainty: a comparative analysis of national health technology assessment agencies in South Korea, England, Australia, and Canada
by: Jihyung Hong, et al.
Published: (2025-01-01) -
Reimbursement or compensation for damages caused by war: the civil law aspect
by: M. О. Parii
Published: (2024-06-01) -
Design, implementation and evaluation of value-based payment models: a Delphi study
by: Diogo L. L. Leao, et al.
Published: (2025-01-01)